Identification of potent inhibitors of ATP synthase subunit c (AtpE) from Mycobacterium tuberculosis using in silico approach

被引:4
|
作者
Isa, Mustafa Alhaji [1 ]
Abubakar, Mustapha B. [2 ]
Mohammed, Mohammed Mustapha [1 ]
Ibrahim, Muhammad Musa [1 ]
Gubio, Falmata Audu [1 ]
机构
[1] Univ Maiduguri, Fac Sci, Dept Microbiol, PMB 1069, Maiduguri, Nigeria
[2] Univ Maiduguri, Fac Vet Med, Dept Vet Microbiol, Maiduguri, Nigeria
关键词
MTB; AtpE; ADME; Homology modeling; MD Simulation; EARLY BACTERICIDAL ACTIVITY; DRUG-RESISTANCE; TARGET; POLYPHENOLS; MUTATIONS; CHEMISTRY; DISCOVERY;
D O I
10.1016/j.heliyon.2021.e08482
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
ATP synthase subunit c (AtpE) is an enzyme that catalyzes the production of ATP from ADP in the presence of sodium or proton gradient from Mycobacterium tuberculosis (MTB). This enzyme considered an essential target for drug design and shares the same pathway with the target of Isoniazid. Thus, this enzyme would serve as an alternative target of the Isoniazid. The three dimensional (3D) model structure of the AtpE was constructed based on the principle of homology modeling using the Modeller9.16. The developed model was subjected to energy minimization and refinement using molecular dynamic (MD) simulation. The minimized model structure was searched against Zinc and PubChem database to determine ligands that bind to the enzyme with minimum binding energy using RASPD and PyRx tool. A total of 4776 compounds capable of bindings to AtpE with minimum binding energy were selected. These compounds further screened for physicochemical properties (Lipinski rule of five). All the compounds that possessed the desirable property selected and used for molecular docking analysis. Five (5) compounds with minimum binding energies ranged between-8.69, and-8.44 kcal/mol, less than the free binding energy of ATP were selected. These compounds further screened for the absorption, distribution, metabolism, excretion, and toxicity (ADME and toxicity) properties. Of the five compounds, three (ZINC14732869, ZINC14742188, and ZINC12205447) fitted all the ADME and toxicity properties and subjected to MD simulation and Molecular Mechanics Generalized Born and Surface Area (MM-GBSA) analyses. The results indicated that the ligands formed relatively stable complexes and had free binding energies, less than the binding energy of the ATP. Therefore, these ligands considered as prospective inhibitors of MTB after successful experimental validation.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Structure of the ATP synthase from Mycobacterium smegmatis provides targets for treating tuberculosis
    Montgomery, Martin G.
    Petri, Jessica
    Spikes, Tobias E.
    Walker, John E.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (47)
  • [22] Molecular models of tryptophan synthase from Mycobacterium tuberculosis complexed with inhibitors
    Dias, MVB
    Canduri, F
    da Silveira, NJF
    Czekster, CM
    Basso, LA
    Palma, MS
    Santos, DS
    de Azevedo, WF
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2006, 44 (03) : 375 - 384
  • [23] Molecular models of tryptophan synthase from Mycobacterium tuberculosis complexed with inhibitors
    Marcio Vinicius Bertacine Dias
    Fernanda Canduri
    Nelson José Freitas da Silveira
    Clarissa Melo Czekster
    Luis Augusto Basso
    Mário Sérgio Palma
    Diógenes Santiago Santos
    Walter Filgueira de Azevedo
    Cell Biochemistry and Biophysics, 2006, 44 : 375 - 384
  • [24] Synthesis of 1,2-Disubstituted Imidazole Derivatives as Potent Inhibitors of Mycobacterium tuberculosis and Their In Silico Studies
    Nadaf, AfraQuasar A.
    Bulbule, Sarojini R.
    Yaseen, Mohammed
    Najare, Mahesh S.
    Mantur, Shivaraj
    Khazi, Imtiyaz Ahmed M.
    CHEMISTRYSELECT, 2021, 6 (01): : 9 - 15
  • [25] Identification of small molecular ligands as potent inhibitors of fatty acid metabolism in Mycobacterium tuberculosis
    Malikanti, Ramesh
    Vadija, Rajender
    Veeravarapu, Hymavathi
    Mustyala, Kiran Kumar
    Malkhed, Vasavi
    Vuruputuri, Uma
    JOURNAL OF MOLECULAR STRUCTURE, 2017, 1150 : 227 - 241
  • [26] An In silico Approach to Identify Potential Inhibitors against Multiple Drug Targets of Mycobacterium tuberculosis
    Kumar, Satish
    Sahu, Parameswar
    Jena, Lingaraja
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2019, 8 (03) : 252 - 261
  • [27] Identification of potential Mycobacterium tuberculosis beta-ketoacyl synthase inhibitors by virtual screening
    Miranda, T. F. N.
    Santos Junior, M. C.
    REVISTA VIRTUAL DE QUIMICA, 2016, 8 (05) : 1740 - 1756
  • [28] Identification of inhibitors targeting polyketide synthase 13 of Mycobacterium tuberculosis as antituberculosis drug leads
    Wang, Xiao
    Zhao, Wenting
    Wang, Bin
    Ding, Wei
    Guo, Hao
    Zhao, Hongyi
    Meng, Jianzhou
    Liu, Sihan
    Lu, Yu
    Liu, Yishuang
    Zhang, Dongfeng
    BIOORGANIC CHEMISTRY, 2021, 114
  • [29] Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis
    Zhang, Wei
    Lung, Shichun
    Wang, Shu-Huan
    Jiang, Xing-Wu
    Yang, Fan
    Tang, Jie
    Manson, Abigail L.
    Earl, Ashlee M.
    Gunosewoyo, Hendra
    Bishai, William R.
    Yu, Li-Fang
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (03) : 791 - 803
  • [30] Molecular modelling of Mycobacterium tuberculosis acetolactate synthase catalytic subunit and its molecular docking study with inhibitors
    Souza, Thais C. S.
    Josa, Daniela
    Ramalho, Teodorico C.
    Caetano, Melissa Soares
    da Cunha, Elaine F. F.
    MOLECULAR SIMULATION, 2008, 34 (07) : 707 - 713